<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">ssmu</journal-id><journal-title-group><journal-title xml:lang="ru">Бюллетень сибирской медицины</journal-title><trans-title-group xml:lang="en"><trans-title>Bulletin of Siberian Medicine</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1682-0363</issn><issn pub-type="epub">1819-3684</issn><publisher><publisher-name>Siberian State Medical University, the Ministry of Healthcare of the Russian Federation</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.20538/1682-0363-2014-1-67-72</article-id><article-id custom-type="elpub" pub-id-type="custom">ssmu-19</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МЕЖДИСЦИПЛИНАРНЫЕ ФУНДАМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ В МЕДИЦИНЕ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>NTERDISCIPLINARY BASIC RESEARCH IN MEDICINE</subject></subj-group></article-categories><title-group><article-title>ЭФФЕКТЫ ГРОССГЕМИНА И ГРОССМИЗИНА ПРИ МОДЕЛИ ОСТРОЙ ГИПЕРЛИПИДЕМИИ, ИНДУЦИРОВАННОЙ ЭТАНОЛОМ</article-title><trans-title-group xml:lang="en"><trans-title>EFFECTS OF GROSSHEMIN AND GROSSMISIN ON THE ACUTE HYPERLIPIDEMIA MODEL INDUCED BY ETHANOL</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ратькин</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ratkin</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Ратькин Александр Валентинович, кандидат фармакологических наук, доцент кафедры фармацевтической технологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кайдаш</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kaidash</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кайдаш Ольга Александровна, аспирант кафедры фармакологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Иванов</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Ivanov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Иванов Владимир Владимирович, кандидат биоогических наук, доцент кафедры биохимии и молекулярной биологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Венгеровский</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Vengerovsky</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Венгеровский Александр Исаакович, доктор медицинских наук, профессор, зав. кафедрой фармакологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Адекенов</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Adekenov</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Адекенов Сергазы Мынжасарович, доктор химических наук, академик НАН РК, председатель правления АО «Международный научно-производственный холдинг „Фитохимия“»</p></bio><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чучалин</surname><given-names>В. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Chuchalin</surname><given-names>V. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Чучалин Владимир Сергеевич, доктор фармакологических наук, зав. кафедрой фармацевтической технологии</p></bio><bio xml:lang="en"/><email xlink:type="simple">midodiclo@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Сибирский государственный медицинский университет, Томск</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Siberian State Medical University, Tomsk</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Международный научно-производственный холдинг „Фитохимия“», АО, Караганда</institution><country>Казахстан</country></aff><aff xml:lang="en"><institution>International Scientific-Industrial Holding “Phytochemistry”, Karaganda</institution><country>Kazakhstan</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>28</day><month>02</month><year>2014</year></pub-date><volume>13</volume><issue>1</issue><fpage>67</fpage><lpage>72</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ратькин А.В., Кайдаш О.А., Иванов В.В., Венгеровский А.И., Адекенов С.М., Чучалин В.С., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Ратькин А.В., Кайдаш О.А., Иванов В.В., Венгеровский А.И., Адекенов С.М., Чучалин В.С.</copyright-holder><copyright-holder xml:lang="en">Ratkin A.V., Kaidash O.A., Ivanov V.V., Vengerovsky A.I., Adekenov S.M., Chuchalin V.S.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://bulletin.ssmu.ru/jour/article/view/19">https://bulletin.ssmu.ru/jour/article/view/19</self-uri><abstract><p>Цель исследования – изучить гиполипидемические свойства сесквитерпеновых лактонов гроссгемина и гроссмизина при модели острой гиперлипидемии, индуцированной этанолом у крыс.Крысам в течение 7 сут вводили в желудок гроссгемин и гроссмизин в дозе 10 мг/кг массы тела или препарат сравнения никотиновую кислоту в дозе 25 мг/кг массы тела. Гиперлипидемию у крыс вызывали однократным внутрижелудочным введением этанола в дозе 5 г/кг массы тела. В сыворотке крови хвостовой вены измеряли содержание триацилглицеридов, общего холестерина, холестерина липопротеинов низкой (ЛПНП) и высокой плотности (ЛПВП), свободных жирных кислот. Вычисляли отношение содержания ЛПВП к количеству холестерина ЛПНП и индекс атерогенности.Однократное введение этанола увеличивало в сыворотке крови уровень триацилглицеридов в 1,9 раза, свободных жирных кислот в 3,2 раза, холестерина ЛПНП – на 44% по сравнению с показателями интактных животных. Это свидетельствует о развитии острой гиперлипидемии. Содержание в сыворотке общего холестерина, холестерина ЛПВП и индекс атерогенности не изменялись.Курсовое введение сесквитерпеновых лактонов гроссгемина и гроссмизина на фоне острой гиперлипидемии сопровождалось снижением в сыворотке крови уровня триацилглицеридов соответственно на 19,8 и 34,1%. Никотиновая кислота уменьшала содержание триацилглицеридов на 42,4%. Гроссгемин и никотиновая кислота снижали повышенный уровень свободных жирных кислот в сыворотке крови крыс на 60,7–67,9%. Гроссмизин и никотиновая кислота уменьшали на 14,6–17,2% уровень общего холестерина.При острой гиперлипидемии гроссгемин и гроссмизин снижали уровень холестерина ЛПНП на 17,6–20,0%, никотиновая кислота – на 15,7%. Оба сесквитерпеновых лактона и никотиновая кислота не изменяли содержания холестерина ЛПВП. При курсовом введении гроссгемина, гроссмизина и никотиновой кислоты отношение содержания холестерина ЛПВП к количеству холестерина ЛПНП достоверно увеличивалось на 42,8; 38,6 и 22,1% соответственноСесквитерпеновые лактоны гроссгемин и гроссмизин обладают гиполипидемическим действием при острой экспериментальной гиперлипидемии, вызванной введением этанола. Лактоны нормализуют многие показатели липидного обмена, что может быть обусловлено разными биохимическими мишенями для этих молекул. Лактоны, как и никотиновая кислота, при модели острой гиперлипидемии снижают в сыворотке крови содержание триацилглицеридов, общего холестерина и холестерина ЛПНП. Гросгемин и никотиновая кислота также уменьшают уровень свободных жирных кислот.</p></abstract><trans-abstract xml:lang="en"><p>Objective: study sesquiterpene lactones grosshemin and grossmisin lipid-lowering properties on the model of acute hyperlipidemia induced by ethanol in rats.Materials and methods. Rats during 7 days injected into the stomach grosshemin and grossmisin in a dose 10 mg/kg or reference drug nicotinic acid in a dose 25 mg/kg. Hyperlipidemia caused by single introduction of ethanol into the stomach in a dose 5 g/kg. In blood serum of tail vein measured the triacylglycerols, total cholesterol, high density and low density lipoproteins cholesterol, also the level of free fatty acids. Calculated the ratio of high density lipoproteins cholesterol to the amount of low density lipoproteins cholesterol and the index of atherogenicity.Results. A single dose of ethanol increased serum level of triacylglycerols in 1.9 times, free fatty acids – in 3.2 times, low density lipoproteins – on 44% in comparison with the intact animals indices. It shows the development of acute hyperlipidemia. Serum total cholesterol, high density lipoproteins cholesterol and the index of atherogenicity were not changed. Course sesquiterpene lactones grosshemin and grossmisin introduction against the background of acute hyperlipidemia was accompanied by a decrease in the serum of triacylglycerols levels respectively by 19.8% and 34.1%. Nicotinic acid lowered the content of triacylglycerols by 42.4%. Grosshemin and nicotinic acid reduced the increased level of free fatty acids in the blood serum by 60.7–67.9%. Grossmisin and nicotinic acid decreased by 14.6–17.2% of total cholesterol in the blood serum. In acute hyperlipidemia grosshemin and grossmisin reduced low density lipoproteins cholesterol by 17.6% and 20%, respectively, nicotinic acid – by 15.7%. Both of sesquiterpene lactone and nicotinic acid did not modify the content of high density lipoproteins cholesterol. When introduction grosshemin, grossmisin and nicotinic acid ratio of high density lipoproteins cholesterol to the amount of low density lipoproteins cholesterol significantly increased by 42.8%, 38,6% and 22.1% respectively.Conclusion. Sesquiterpene lactones grosshemin and grossmisin posses hypolipidemic effect in acute experimental hyperlipidemia caused by the ethanol introduction. Lactones normalize many indices of lipid metabolism, which can be caused by different biochemical targets of these molecules. Lactones, as nicotinic acid, in the model of acute hyperlipidemia decrease in blood serum triacylglycerols, total cholesterol, and low density lipoproteins cholesterol content. Grosshemin and nicotinic acid also reduce the free fatty acids level.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>экспериментальная гиперлипидемия</kwd><kwd>этанол</kwd><kwd>гроссгемин</kwd><kwd>гроссмизин</kwd><kwd>никотиновая кислота</kwd><kwd>липолиз</kwd></kwd-group><kwd-group xml:lang="en"><kwd>experimental  hyperlipidemia</kwd><kwd>ethanol</kwd><kwd>grosshemin  and  grossmisin</kwd><kwd>nicotinic  acid</kwd><kwd>lipolysis</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Совет по грантам Президента Российской Федерации</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Hansson G.K., Robertson A.-K.L., Söderberg-Naucler C. In-flammation and atherosclerosis // Annu. Rev. Pathol. Mech. Dis. 2006. Vol. 1, № 2. P. 297–329.</mixed-citation><mixed-citation xml:lang="en">Hansson G.K., Robertson A.-K.L., Söderberg-Naucler C. Inflammation and atherosclerosis. Annu. Rev. Pathol. Mech. Dis., 2006, vol. 1, no. 2, pp. 297–329.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Atherosclerosis – Diet-induce atherosclerosis/hypercholeste¬rolemia in rodent models / ed. M.A. Pellizzon. URL: http://www.researchdiets.com/product-literature</mixed-citation><mixed-citation xml:lang="en">Atherosclerosis – Diet-induce atherosclerosis/hypercholesterolemia   in   rodent   models.   Ed.   M.A. Pellizzon.   URL: http://www.researchdiets.com/product-literature</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">VanderLaan P.A., Reardon С.А. The unusual suspects: an overview of the minor leucocyte populations in atherosclero-sis // J. Lipid Res. 2005. Vol. 46, № 7. P. 829–838.</mixed-citation><mixed-citation xml:lang="en">VanderLaan P.A.,  Reardon С.А.  The  unusual  suspects:  an overview of the minor leucocyte populations in atherosclerosis. J. Lipid Res., 2005, vol. 46, no. 7, pp. 829–838.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Буеверова Е.Л., Драпкина О.М., Ивашкин В.Т. Атероген-ная дислипидемия и печень // Рос. мед. вести. 2008. Т. 13, № 1. С. 17–23.</mixed-citation><mixed-citation xml:lang="en">Bueverova  E.L.,  Drapkina  O.M.,  Ivashkin  V.T.  Russian Medical News, 2008, vol. 13, no. 1, pp. 17–23 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) // JAMA. 2001. V. 285, № 12. P. 2486–2497.</mixed-citation><mixed-citation xml:lang="en">Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001, vol. 285, no. 12, pp. 2486–2497.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Василенко Ю.К., Лисевицкая Л.И., Фролова Л.М., Пар-фентьева Е.П., Скульте И.В., Василенко А.Ю., Кожар-ский В.В., Восканян В.Л. Гиполипидемические свойства тритерпеноидов // Хим.-фарм. журн. 1982. Т. 45, № 5. С. 66–70.</mixed-citation><mixed-citation xml:lang="en">Vasilenko    Yu.K.,    Lisevitskaya    L.I.,    Frolova    L.M., Parfentieva Ye.P., Skulte I.V., Vasilenko A.Yu., Kozharsky V.V., Voskanyan V.L. Chem.-Farm. Journal, 1982, vol. 45, no. 5, pp. 66–70 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Shimoda H., Ninomiya K., Nishida N. et al. Anti-hyperlipi¬demic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure re-quirement and mode of action // Bioorg. Med. Chem. Lett. 2003. V. 13, № 2. P. 223–228.</mixed-citation><mixed-citation xml:lang="en">Shimoda H.,    Ninomiya K.,    Nishida N.    et    al.    Antihyperlipidemic sesquiterpenes and new sesquiterpene glycosides from the leaves of artichoke (Cynara scolymus L.): structure requirement and mode of action. Bioorg. Med. Chem. Lett., 2003, vol. 13, no. 2, pp. 223–228.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Eliza J., Daisy P., Ignacimuthu S., Duraipandiyan V. Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.) Sm., in STZ-induced diabetic rats // Chem. Biol. Interact. 2009. V. 182, № 1. P. 67–72.</mixed-citation><mixed-citation xml:lang="en">Eliza J.,     Daisy P.,     Ignacimuthu S.,     Duraipandiyan V. Antidiabetic and antilipidemic effect of eremanthin from Costus speciosus (Koen.) Sm., in STZ-induced diabetic rats. Chem. Biol. Interact., 2009, vol. 182, no. 1, pp. 67–72.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kim S.H., Park K.S. Effects of Panax ginseng extract on lipid metabolism in humans // Pharmacol. Res. 2003. V. 48, № 5. P. 511–513.</mixed-citation><mixed-citation xml:lang="en">Kim S.H., Park K.S. Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol. Res., 2003, vol. 48, no. 5, pp. 511–513.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Hennekens C.H. Current perspectives on lipid lowering with statins to decrease risk of cardiovascular disease // Clin. Car-diol. 2001. V. 24, № 7. P. 2–5.</mixed-citation><mixed-citation xml:lang="en">Hennekens C.H. Current perspectives on lipid lowering with statins to decrease risk of cardiovascular disease. Clin. Cardiol., 2001, vol. 24, no. 7, pp. 2–5.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Кагарлицкий А.Д., Адекенов С.М., Куприянов А.Н. Сеск-витерпеновые лактоны растений Центрального Казах-стана. Алма-Ата: Наука, 1987. 240 с.</mixed-citation><mixed-citation xml:lang="en">Kagarlitsky   A.D.,   Adekenov   S.M.,   Kupriyanov   A.N. Sesquiterpene lactones plants of Central Kazahstan. AlmaAta. Science Publ., 1987. 240 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Руководство по проведению доклинических исследова-ний лекарственных средств. Ч. 1 / под ред. А.И. Мироно-ва. М.: Гриф и К, 2013. 944 с.</mixed-citation><mixed-citation xml:lang="en">Guidelines  for  pre-clinical  trials  of  drugs.  Part  1.  Ed. A.I. Mironov. Moscow, Grif and Co. Publ., 2013. 944 p. (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sapronov N.S., Khnychenko L.K., Okunevich I.V., Gav-rovskaya L.K. Potential antiatherosclerotic drugs: novel N-substituted taurinamide derivatives // Adv. Exp. Med. Biol. 2006. V. 583. P. 515–521.</mixed-citation><mixed-citation xml:lang="en">Sapronov N.S.,         Khnychenko L.K.,         Okunevich I.V., Gavrovskaya L.K. Potential antiatherosclerotic drugs: novel N-substituted taurinamide derivatives. Adv. Exp. Med. Biol., 2006, vol. 583, pp. 515–521.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Bodor E.T., Offermanns S. Nicotinic acid: an old drug with a promising future // Br. J. Pharmacol. 2008. Vol. 153, № 1. P. 68–75.</mixed-citation><mixed-citation xml:lang="en">Bodor E.T., Offermanns S. Nicotinic acid: an old drug with a promising future. Br. J. Pharmacol., 2008, vol. 153, no. 1, pp. 68–75.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ren N., Kaplan R., Hernandez M. et al. Phenolic acids sup-press adipocyte lypolisis via activation of the nicotinic acid receptor GRP109A (HM74a/PUMA-G) // J. Lipid Res. 2011. V. 50, № 5. P. 908–914.</mixed-citation><mixed-citation xml:lang="en">Ren N., Kaplan R., Hernandez M. et al. Phenolic acids suppress adipocyte lypolisis via activation of the nicotinic acid receptor GRP109A (HM74a/PUMA-G). J. Lipid Res., 2011, vol. 50, no. 5, pp. 908–914.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
